Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer

Annals of Surgical Oncology

Volumn 15, Issue 12, 2008, Pages 3433-3439

  Takagawa, Ryo ^a   Fujii, Syoichi ^a   Ohta, Mitsuyoshi ^a   Nagano, Yasuhiko ^a   Kunisaki, Chikara ^a   Yamagishi, Shigeru ^b   Osada, Shunichi ^b   Ichikawa, Yasushi ^b   Shimada, Hiroshi ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; COLORECTAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BRAIN NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PERITONEAL NEOPLASMS; PREOPERATIVE CARE; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 58149289980     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0168-8     Document Type: Article

References (33)

1. M Marugame K-I Kamo K Katanoda 2004 Cancer incidence and incidence rate in Japan in 1999: estimates based on data from 11 population-based cancer registries Jpn J Clin Oncol 34 352 6
2. Japanese Society for Cancer of the Colon and Rectum: multi-institutional of Large Bowel Cancer in Japan, Cause treated in 1995-1998. Vol 17 (1999), Vol 18 (2000), Vol 21 (2001), Vol 24 (2003). Kinbara, Tokyo, Japan
3. CG Moertel TR Fleming JS Macdonald 1990 Levamisole and fluorouracil as adjuvant therapy of resected colon carcinoma N Engl J Med 32 352 8
4. N Wolmark H Rockette B Fisher 1993 The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: result from National Surgical Adjuvant Breast and Bowel Project protocol C-03 J Clin Oncol 11 1879 87
5. International Multicentre Pooled Analysis of Colon Cancer Trial (IMPACT) Investigators 1995 Efficacy of adjuvant fluorouracil and folinic acid in colon cancer Lancet 345 937 44
6. MJ O'Connell JA Laurie M Kahn 1998 Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer J Clin Oncol 16 295 300
7. T Andre C Boni A Gramont 2004 Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer New Engl J Med 350 2343 51
8. C Twelves A Wong W Scheithauer 2005 Capecitabine as adjuvant treatment for stage III colon cancer New Engl J Med 352 2696 704
9. A de Gramont A Figer M Seymour 2000 Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 22 229 37
10. JY Douillard D Cunningham AD Roth 2000 Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial Lancet 355 1041 7
11. H Herwits L Fehrenbacher W Novotny 2004 Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2335 42
12. CB Wood JG Ratcliffe RW Burt 1980 The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer Br J Surg 67 46 48
13. MW Wichmann C Müller U Lau-Werner 2000 The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer Langenbecks Arch Surg 385 271 5
14. I Chau MJ Allen D Cunningham 2004 The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer J Clin Oncol 22 1420 9
15. JL McCall RB Black J Toouli 1994 The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer Dis Colon Rectum 37 875 81
16. HJ Wanebo B Rao CM Pinsky 1978 The use of preoperative carcinoembryonic antigen level as a prognostic indicator to complement pathological staging N Engl J Med 299 448 51
17. MW Wichmann U Lau-Werner C Müller 2000 Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer Anticancer Res 20 4953 5
18. MJ Goldstein EP Mitchell 2005 Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer Cancer Invest 23 338 51
19. L Lipská V Visokai M Levý 2007 Tumor markers in patients with relapse of colorectal carcinoma Anticancer Res 27 1901 5
20. J Watine M Miedouge B Friedberg 2001 Carcinoembryonic antigen as an independent prognostic factor of recurrence and survival in patients resected for colorectal liver metastases: a systematic review Dis Colon Rectum 44 1791 9
21. S Wiratkapun M Kraemer KW Eu 2004 High preoperative serum carcinoembryonic antigen predicts metastatic recurrence in potentially curative colonic cancer: results of a five-year study Dis Colon Rectum 44 231 5
22. P Gold SO Freedman 1965 Demonstration of tumor specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques J Exp Med 121 439 62
23. CG Moertel JR O'Fallon VLW Go 1986 The preoperative carcinoembryonic antigen test in the diagnosis, staging and prognosis of colorectal cancer Cancer 58 603 10
24. LE Harrison JG Guillem AM Cohen 1997 Preoperative carcinoembryonic antigen predict outcomes in node-negative colon cancer patients: A multivariate analysis of 512 patients J Am Coll Surg 185 55 9
25. K Slentz A Senagore J Hibert 1994 Can preoperative and postoperative CEA predict survival after colon cancer resection? Am Surg 60 528 32
26. JY Wang CY Lu JS Hsieh 2007 Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer Eur Surg Res 39 245 50
27. AI Behbehani H Al-Sayer M Farghaly 2000 Prognostic significance of CEA and CA 19-9 in colorectal cancer in Kuwait Int J Biol Markers 15 51 5
28. ML Julia MM Cassandra EH Jennifer 2006 Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells Clin Cancer Res 12 417 23
29. S Sadahiro T Suzuki H Makuuchi 2006 Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer Ann Surg Oncol 14 1092 8
30. JY Park KH Lee 2007 Carcinoembryonic antigen and patterns of recurrence after curative resection of the colorectal cancer Hepatogastroenterology 54 1966 9
31. S Eggington P Tappenden A Pandor 2006 Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer Br J Cancer 95 1195 201
32. S Aballéa JV Chancellor M Raikou 2007 Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US Cancer 109 1082 9
33. S Aballéa A Boler A Craig 2007 An economic evaluation of oxaliplatin for the adjuvant treatment of colon cancer in the United Kingdom (UK) Eur J Cancer 43 1687 93